Both in Pharmaceuticals
Zevra Therapeutics vs Nuvectis Pharma
Over the past year ZVRA returned +18.9% and NVCT returned +246.8%; their daily moves had a correlation of 0.14.
ZVRA +18.9% NVCT +246.8%Growth of $1, one year, split-adjusted
| Metric | ZVRA | NVCT |
|---|---|---|
| Price | $11.34 | $20.53 |
| Market cap | $673.4M | $670.2M |
| Today | +0.35% | −1.35% |
| 1 month | −1.9% | −13.5% |
| 6 months | +29.2% | +174.1% |
| Year to date | +26.6% | +171.9% |
| 1 year | +16.1% | +237.7% |
| Revenue growth (YoY) | +53.3% | — |
| Gross margin | 96.2% | — |
| Net margin | 21.2% | — |
| P/E (TTM) | 11.6× | — |
| Price / sales | 4.9× | — |
| Net cash | $221.6M | $22.2M |
| Dividend yield | — | — |
| Volatility (60d) | 72.1% | 68.0% |
| Short % of float | 10.0% | 10.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).